H2020 EU Biomolmacs

EU Horizon2020 project: BIOMOLMACS

Innovative Training Networks (ITN) Call: H2020-MSCA-ITN-2019   The main aim of the project BIOMOLMACS is to establish a multidisciplinary training network on the emerging topic of molecular machines. In the last decades, great efforts have been spent on the development of synthetic strategies for the creation of molecular machines, and these efforts have been acknowledged…

PTS (Polypeptide Therapeutic Solutions)

More about PTS (Polypeptide Therapeutic Solutions)

PTS is a company devoted to the design and manufacture of polypeptide-based materials for drug delivery and high-tech applications. With more than 30 years of experience in polypeptide & materials science, drug delivery, custom manufacturing, analytical characterization and quality assurance we are committed to one purpose, your success. Our novel technology (patented) and strong know-how in…

PolyPepSkin project

PolyPepSkin project: new topical treatments based on polypeptide carriers receive funding from the Ministry of Economy and Competitiveness

The research project PolyPepSkin will focus on the development of new topical therapies for the treatment of inflammatory skin diseases such as psoriasis. The new approach consists in using novel biodegradable and biocompatible hydrogels based on copolymers of polysaccharides -polyaminoacids/polypeptides as transdermal permeation enhancers transporting anti-inflammatory drugs.   A collaboration between scientists of three public…

PTS: primera planta europea polipéptidos

PTS INAUGURA LA PRIMERA PLANTA EN EUROPA PARA FABRICAR POLIPÉPTIDOS

La empresa valenciana PTS acabamos de inaugurar la primera planta en Europa capaz de fabricar kilos de polipéptidos, polímeros avanzados que imitan a la naturaleza y llevan el fármaco allí donde se necesita, con su metodología patentada.   Inmunoterapia, oncología, enfermedades neurodegenerativas, infecciones bacterianas, terapias génicas… ¿Qué tienen en común? Todas pueden ser tratadas con…

PTS will attend the 10th DDF Summit 2019 in Berlin

Find us at booth nº 12, partnered with In collaboration with PMC Isochem, PTS will be presenting the global solutions in polypeptides-based materials for drug delivery. PTS offers the entire development of the product, from R&D through scale up to GMP manufacturing and analytical support in a GLP certified laboratory. Preclinical, clinical and commercial batches…

Proyecto PTS 2018

Polypeptide Therapeutic Solutions, S.L. ha desarrollado con éxito durante 2018 un proyecto denominado “DESARROLLO Y VALIDACIÓN DE METODOLOGÍAS ANALÍTICAS PARA ANÁLISIS DE HIDROGELES COMO MATRIZ DE MATERIALES POLIPEPTÍDICOS” para el que ha contado con el apoyo de la Agencia Valenciana de la Innovación, a través de su programa de apoyo “Promoción del talento”, en su…

PharmaIN Corporation and Polypeptide Therapeutic Solutions announces a collaboration agreement for contract manufacturing

Bothell, WA & Valencia, Spain – 21st September 2018 PharmaIN Corporation and Polypeptide Therapeutic Solutions (PTS) announced today that they have entered into a collaboration agreement for contract manufacturing. Under the agreement, Polypeptide Therapeutic Solutions will provide PharmaIN contract research services and own technology to add as a part of PharmaIN´s Protected Graft Co-Polymer (PGCTM)…